Shahid Beheshti University of Medical Sciences
  • New Submission
  • Privacy Statement
  • Register
  • Copyright Notice
  • Archiving
  • Login
  1. Home
  2. Archives
  3. Vol. 7 (2022): Continuous Volume (online only)
  4. Letter to Editor

Focus and Scope

Editorial Team

Abstracting & Indexing

Metrics

Current Issue

Archives

Ethical considerations of animals and human studies

Allegation of misconduct

Plagiarism Checking Policy

Open Access Policy

Archiving

Copyright Notice

Privacy Statement

Peer Review Process

Preprint Policy

Peer-review policy (ethics and competing interest)

Post-publication discussion and correction

Complaints and appeals

Publication Fees

Author Guideline

Author Guideline (PDF)

Using Artificial Intelligence (AI) in the Manuscript Preparation

Authorship Policies

conflict of interest

Risk of Outbreak Omicron Virus by Increasing the Number of Mutations in the Receptor Binding Domain (RBD) Increasing number of mutations in RBD in Omicron outbreak

  • Mehdi Pooladi
  • Soheila Karani

Trends in Peptide and Protein Sciences, Vol. 7 (2022), 7 March 2022 , Page 1-3 (e1)
https://doi.org/10.22037/tpps.v7i.37447 Published: 2022-03-07

  • View Article
  • Download
  • Cite
  • References
  • Statastics
  • Share

Abstract

HIGHLIGHTS

  • Rapid spread of Omicron variant is a serious challenge.
  • More than 50 mutations have occurred in Omicron variant.
  • The mutations have caused the RBD structure to undergo significant changes
Keywords:
  • Mutation
  • Omicron
  • Receptor binding domain (RBD)
  • Spike protein
  • PDF

How to Cite

1.
Pooladi M, Karani S. Risk of Outbreak Omicron Virus by Increasing the Number of Mutations in the Receptor Binding Domain (RBD): Increasing number of mutations in RBD in Omicron outbreak. Trends Pept. Protein Sci. [Internet]. 2022 Mar. 7 [cited 2026 Nov. 16];7:1-3 (e1). Available from: https://journals.sbmu.ac.ir/protein/article/view/37447
  • ACM
  • ACS
  • APA
  • ABNT
  • Chicago
  • Harvard
  • IEEE
  • MLA
  • Turabian
  • Vancouver
  • Endnote/Zotero/Mendeley (RIS)
  • BibTeX

References

Cohen, J. (2021). ″Omicron sparks a vaccine strategy debate.″ Science, 374(6575):1561-1562. DOI: 10.1126/science.acz9879.

Cross, R. (2021). ″Omicron puts scientists on red alert.″ C&EN Global Enterprise, 99 (44): 6-6. DOI: 10.1021/cen-09944-leadcon.

Graham, F. (2021). ″Daily briefing: Omicron might weaken vaccine protection.″ Nature Briefing. DOI: 10.1038/d41586-021-03689-8.

Hastie, K.M., Li, H., Bedinger, D., Schendel, S.L., Dennison, S.M., Li, K. and E.O. Saphire, (2021). ″Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study.″ Science, 374(6566): 472-478. DOI: 10.1126/science.abh2315.

Karim, S.S.A. and Q.A. Karim, (2021). ″Omicron SARS-CoV-2 variant: A new chapter in the COVID-19 pandemic.″ The Lancet, 398(10317): 2126-2128. DOI: 10.1016/S0140-6736(21)02758-6.

Kim, S., Nguyen, T. T., Taitt, A. S., Jhun, H., Park, H. Y., Kim, S. H. and S. Kim, (2021). ″SARS-CoV-2 Omicron mutation is faster than the chase: Multiple mutations on Spike/ACE2 interaction residues.″ Immune Network, 21(6): e38. DOI: 10.4110/in.2021.21.e38.

Kumar, S., Thambiraja, T.S., Karuppanan, K. and G. Subramaniam, (2021). ″Omicron and Delta variant of SARS‐CoV‐2: A comparative computational study of spike protein.″ Journal of Medical Virology, 2021: 1–9. DOI: 10.1002/jmv.27526.

Li, A., Maier, A., Carter, M. and T Hugh Guan, (2021). ″Omicron and S‐gene target failure cases in the highest COVID‐19 case rate region in Canada - December 2021.″ Journal of Medical Virology. 2022:1-3. DOI: 10.1002/jmv.27562.

Meo, S.A., Meo, A.S., Al-Jassir, F.F. and D.C. Klonoff, (2021). ″Omicron SARS-CoV-2 new variant: global prevalence and biological and clinical characteristics. European Review for Medical and Pharmacological Sciences, 25(24): 8012-8018. DOI: 10.26355/eurrev_202112_27652.

Pooladi, M., Entezari, M., Hashemi, M., Bahonar, A., Hushmandi, K. and M. Raei, (2020). Investigating the efficient management of different countries in the COVID-19 pandemic.″ Journal of Marine Medicine, 2(1):18-25. DOI :10.30491/2.1.3.

Pooladi, M., Hushmandi, K. and M. Entezari, (2021). ″Risk of increased expression of ACE2 membrane protein in patients with hypertension: Review of COVID-19.″ Archives of Advances in Biosciences, 12(1): 52-64. DOI.org/10.22037/aab.v12i1.30521.

Rath, S.L., Padhi, A.K. and N. Mandal, (2022). ″Scanning the RBD-ACE2 molecular interactions in Omicron variant.″ Biochemical and Biophysical Research Communications, 592:18-23. DOI: 10.1016/j.bbrc.2022.01.006.

Sharma, S.R. (2021). ″Omicron sets alarm bells ringing.″ Homoeopathic Links, 34(04): 255-256. DOI: 10.1055/s-0041-1741016.

  • Abstract Viewed: 202 times
  • PDF Downloaded: 191 times

Download Statastics

  • Linkedin
  • Twitter
  • Facebook
  • Google Plus
  • Telegram

Developed By

Open Journal Systems

Make a Submission

Make a Submission

Information

  • For Readers
  • For Authors
  • For Librarians

society

Iranian Association of Pharmaceutical Scientists

  • Home
  • Archives
  • Submissions
  • About the Journal
  • Editorial Team
  • Contact

All open-access articles of TPPS are distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0).

Journal Name:

Trends in Peptide and Protein Sciences (TPPS)

Journal Abbreviation:

Trends Pept. Protein Sci.

eISSN:

2538-2446

 

 

 

Powered by OJSPlus